The article has been automatically translated into English by Google Translate from Russian and has not been edited.
Переклад цього матеріалу українською мовою з російської було автоматично здійснено сервісом Google Translate, без подальшого редагування тексту.
Bu məqalə Google Translate servisi vasitəsi ilə avtomatik olaraq rus dilindən azərbaycan dilinə tərcümə olunmuşdur. Bundan sonra mətn redaktə edilməmişdir.

The first child with antibodies to COVID-19 was born in the USA: how is this possible

The first child in the United States was born with antibodies against COVID-19 after mom received a dose of Moderna vaccine during pregnancy. The edition told in more detail CBS News.

Photo: Shutterstock

At 36 weeks pregnant, a South Florida healthcare professional received her first dose of Moderna COVID-19 vaccine. Three weeks later, she gave birth to a healthy baby girl with antibodies to this type of coronavirus.

Doctors believe the newborn is the first known birth of a child in the United States with antibodies to COVID-19.

Dr. Paul Giblert and Dr. Chad Rudnik found the antibodies were found during labor after testing a blood sample from the baby's umbilical cord taken immediately after birth and before delivery.

“We found that SARS-CoV-2 IgG antibodies are detectable in a newborn cord blood sample after a single dose of Moderna vaccine,” they concluded. "So there is potential to protect and reduce the risk of Sars-CoV-2 infection when the mother is vaccinated."

However, doctors emphasize that more research is needed to test the safety and efficacy of coronavirus vaccines during pregnancy.

It was already known that mothers previously infected with COVID-19 can transmit antibodies to their young. In addition, the transmission of antibodies from mother to child through the placenta has been well documented in other vaccines, including influenza, so doctors hoped that the same protection for newborns would be possible after the mother was vaccinated against COVID-19.

On the subject: FDA approves emergency treatment for COVID-19 with antibodies: what is this method

“This is really the beginning of aligning the COVID-19 vaccine with those vaccines we already use for pregnant women, such as the flu vaccine,” said Dr. Nita Ogden, internal medicine specialist, immunologist. "We need serious data on how safe it is."

These early results may give pregnant women more reason to consider getting vaccinated.

“This is encouraging because it provides a certain level of protection for one of the most vulnerable populations - the newborn,” Ogden said, but stressed the need to further explore the issue.

Since there are no approved childhood vaccines against COVID-19 yet, she is convinced: "If we can see such a safe transfer of maternal antibodies from the vaccine to newborns, then in my opinion, this is really a big step in the right direction."

Other recent studies, published in the preprint and not peer reviewed, support the findings.

Massachusetts Hospital recently examined 131 women: 84 pregnant, 31 breastfeeding, and 16 non-pregnant. They all received Pfizer or Moderna vaccines. Equally strong immune responses were found both in pregnant and lactating women and in the control group. In addition, antibodies were present in the placenta and breast milk of each sample taken.

“Antibodies produced by the maternal vaccine were detected in the umbilical cord blood of all 10 babies born during the study period,” said co-author Dr. Andrea Adlow, specialist in maternal and fetal medicine at Massachusetts Hospital. "Our data shows that receiving both injections of the mRNA vaccine results in improved transmission of antibodies to newborns."

You may be interested in: top New York news, stories of our immigrants and helpful tips about life in the Big Apple - read it all on ForumDaily New York

Another study in Israel found antibodies in all 20 women tested who received both doses of Pfizer vaccine.

In February, Pfizer announced that it had begun the first large-scale trial of its vaccine in pregnant women, which is expected to be completed by early 2023. Her vaccine was approved for emergency use in the United States in December, and millions of people, including thousands of pregnant women, have already been vaccinated.

Johnson & Johnson, which was approved for emergency use of the vaccine in February, said it plans to include pregnant women and their babies in its studies and collect data on pregnant women through the registry.

Note that pregnant women were excluded from the initial trials of the Moderna and Pfizer COVID-19 vaccines, which is common practice in such studies.

Read also on ForumDaily:

Allergies and autoimmune diseases can be cured forever: scientists have found a way

Horns will grow, autism or cancer will develop: the most popular myths-horror stories about vaccinations

Traditional Johnson & Johnson vs. Pfizer and Moderna with mRNA: Which Vaccine to Choose

How viruses arise and why their massive outbreaks are not accidental: the opinion of the epidemiologist

In the U.S. child COVID-19: antibodies
Subscribe to ForumDaily on Google News

Do you want more important and interesting news about life in the USA and immigration to America? Subscribe to our page in Facebook. Choose the "Display Priority" option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram - there are many interesting things. And join thousands of readers ForumDaily Woman и ForumDaily New York - there you will find a lot of interesting and positive information. 



 
1076 requests in 2,248 seconds.